Chris Liddle
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 3
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
- Lung Cancer Research Studies 1
- Co-authors
- GC Farrell (1 shared paper)Peter Charlton (3 shared papers)Prakash Mistry (3 shared papers)Wendy Dangerfield (3 shared papers)Alistair Stewart (3 shared papers)Douglas Bootle (2 shared papers)Jane A. Plumb (1 shared paper)David J. Templeton (1 shared paper)
- Journals
- Hepatology (2 papers)Gastroenterology (1 paper)Biochemical and Biophysical Research Communications (1 paper)Anti-Cancer Drugs (1 paper)Oncotarget (1 paper)
- Partner nations
- AustraliaNew ZealandUnited Kingdom
In The Last Decade
Chris Liddle
16 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Hepatology 193
- Toxicology 57
- Epidemiology 442
- Oncology 334
- Endocrinology, Diabetes and Metabolism 141
Countries citing papers authored by Chris Liddle
This map shows the geographic impact of Chris Liddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Liddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Liddle more than expected).
Fields of papers citing papers by Chris Liddle
This network shows the impact of papers produced by Chris Liddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Liddle. The network helps show where Chris Liddle may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Liddle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 349 | |
| 2 | In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. | 2001 | 309 |
| 3 | 2000 | 140 | |
| 4 | 2002 | 119 | |
| 5 | 2020 | 67 | |
| 6 | 2002 | 56 | |
| 7 | 1998 | 44 | |
| 8 | 2009 | 43 | |
| 9 | 1987 | 23 | |
| 10 | 2013 | 21 | |
| 11 | 2003 | 18 | |
| 12 | 2013 | 17 | |
| 13 | 2005 | 16 | |
| 14 | 2016 | 15 | |
| 15 | 2007 | 9 | |
| 16 | 2010 | 1 |
About Chris Liddle
Chris Liddle is a scholar working on Molecular Biology, Oncology, Epidemiology, Hepatology and Genetics, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Hepatitis C virus research (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Hepatology (193 citations), Toxicology (57 citations), Epidemiology (442 citations), Oncology (334 citations) and Endocrinology, Diabetes and Metabolism (141 citations). Chris Liddle has collaborated with scholars based in Australia, New Zealand and United Kingdom. Frequent co-authors include GC Farrell, Peter Charlton, Prakash Mistry, Wendy Dangerfield, Alistair Stewart, Douglas Bootle, Jane A. Plumb, David J. Templeton, Dev Samarasinghe and Rita Lin. Their work appears in journals such as Hepatology, Gastroenterology, Biochemical and Biophysical Research Communications, Anti-Cancer Drugs and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.